Ignite Creation Date:
2024-05-06 @ 9:37 AM
Last Modification Date:
2024-10-26 @ 12:17 PM
Study NCT ID:
NCT03029988
Status:
TERMINATED
Last Update Posted:
2020-09-10
First Post:
2017-01-20
Brief Title:
An Evaluation of Tilmanocept by IV Injection Using SPECTCT vs PET Imaging in Subjects With Liver Metastases
Sponsor:
Navidea Biopharmaceuticals
Organization:
Navidea Biopharmaceuticals
Organization Data
Organization:
Navidea Biopharmaceuticals
Class:
INDUSTRY
Study ID:
NAV3-25
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Navidea Biopharmaceuticals
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute NCI | NIH |
| National Institutes of Health NIH | NIH |